Oct 23,2024

A Review of Four Promising Digital Health Solutions in Oncology

Digital health (DH) is transforming healthcare delivery and improving patient outcomes while reducing costs. Various stakeholders, including pharmaceutical companies, hospitals, payers, advocacy groups, and tech firms, are developing and implementing DH tools. Despite its potential, the adoption of DH solutions in oncology remains low compared to areas like diabetes and cardiovascular disease. This report defines four promising categories of DH solutions in oncology and analyzes the current state of each.

View Analyst & Ambassador Comments
Go to original news
Sep 04,2024

Tempus Announces Real World Data Collaboration with BioNTech

Tempus AI announced a multi-year collaboration with BioNTech SE , a global next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. This collaboration leverages Tempus’ multimodal datasets in support of BioNTech’s next-generation oncology pipeline. Under this collaboration, Tempus is providing analytical support and computational biology expertise to BioNTech across its comprehensive research and development oncology pipeline. BioNTech will work collaboratively with Tempus to leverage Tempus’ real-world multimodal database to generate novel insights into the biological mechanisms supporting the discovery of new therapies and aiming to enhance the development of BioNTech’s clinical oncology pipeline.

COLLABORATION PARTNERSHIP

#data & technology

#rwd

View Analyst & Ambassador Comments
Go to original news
Aug 19,2024

Owkin Collaborates with MSD to Assess the Impact of MSIntuit® CRC to Accelerate Patient Identification for Therapeutic Decisions

Owkin has entered into a collaborative pilot program with MSD (Merck & Co., Inc., Rahway, NJ, USA) to assess the impact of MSIntuit® CRC, an innovative digital pathology diagnostic solution, on overall patient identification leading to therapeutic decisions. The pilot program aims to evaluate the efficiency and work-flow impact of integrating MSIntuit® CRC into current patient identification diagnostic journey  by generating evidence within a clinical diagnostic pathology setting. Crucially, it will measure resource utilization, overall user experience, and the impact of MSIntuit® CRC in accelerating patient identification, providing insights into the effectiveness of AI-algorithm driven diagnostics in routine clinical practice. This program will be conducted in select European sites that include Germany, France, and the United Kingdom, with a potential expansion to other countries.

COLLABORATION PARTNERSHIP

#r&d

#ai/software

#clinical decision support

View Analyst & Ambassador Comments
Go to original news
Aug 01,2024

New AI Tool Predicts Risk for Chronic Pain in Cancer Patients

A new study by researchers at the University of Florida and other institutions uses AI to predict which breast cancer patients are most likely to develop chronic pain, a condition that affects about one-third of cancer patients and can significantly impact their quality of life. The AI model, developed using data from over 1,000 patients, correctly predicted chronic pain in more than 80% of cases. Key risk factors include anxiety, depression, prior cancer diagnoses, and certain infections. The findings, published in the Journal of Nursing Scholarship on July 26, highlight the potential of AI to personalize treatments by identifying at-risk patients early on. Integrating this model into healthcare systems would require further research, but it could enhance doctors' ability to tailor treatments to individual needs.

CLINICAL STUDY

#ai/software

View Analyst & Ambassador Comments
Go to original news
Sep 03,2024

Blackford and Coreline Commercial Partnership

Blackford and Coreline, a leading provider of AI solutions for lung cancer screening, announced a commercial partnership to bring Coreline’s AVIEW solutions for thoracic CT to healthcare professionals via the Blackford Platform. Integrating Coreline's comprehensive technology into the Blackford Platform equips healthcare providers with potent tools for detecting thoracic diseases. 

COLLABORATION PARTNERSHIP

#institution

#ai/software

#clinical decision support

View Analyst & Ambassador Comments
Go to original news
Jun 03,2024

Mika Health, Cancer Support Community partner on AI oncologic digital therapeutic

Mika Health, a digital therapeutics company focused on oncology, has partnered with the global nonprofit Cancer Support Community (CSC) to provide a free AI-enabled digital therapeutic to U.S. cancer patients and their caregivers. The app offers psychological support to reduce anxiety, depression, and stress, as well as tools for tracking medication side effects, receiving reminders, and coordinating care. Already certified in the EU, the therapeutic will now be available in North America. The partnership aims to expand access through CSC's network and develop multicultural components to improve health equity. Additionally, they will conduct research to enhance patient and caregiver outcomes.

COLLABORATION PARTNERSHIP

#institution

#dtx

View Analyst & Ambassador Comments
Go to original news
Mar 05,2024

Osara Health announces partnership with Allstate Benefits to offer members cancer care support

Osara Health, a leader in behavior change interventions for cancer, has partnered with Allstate Benefits, a prominent health and supplemental insurer, to provide comprehensive cancer support to members of Allstate's group health benefits program. This partnership marks a first in the U.S. health insurance market, offering Osara’s clinically validated program aimed at improving the quality of life and enabling faster return to work for cancer patients. Osara’s program, developed by oncologists, addresses significant gaps in cancer care, particularly in symptom management, which can reduce healthcare costs and emergency visits. The partnership expands Osara's reach in the U.S., enhancing support for cancer patients while reinforcing Allstate Benefits' commitment to comprehensive member care.

COLLABORATION PARTNERSHIP

#insurance

#virtual care

#coaching

View Analyst & Ambassador Comments
Go to original news
Jun 03,2024

Mika Health, Cancer Support Community partner on AI oncologic digital therapeutic

Mika Health, a digital therapeutics company focused on oncology, has partnered with the global nonprofit Cancer Support Community (CSC) to provide a free AI-enabled digital therapeutic to U.S. cancer patients and their caregivers. The app offers psychological support to reduce anxiety, depression, and stress, as well as tools for tracking medication side effects, receiving reminders, and coordinating care. Already certified in the EU, the therapeutic will now be available in North America. The partnership aims to expand access through CSC's network and develop multicultural components to improve health equity. Additionally, they will conduct research to enhance patient and caregiver outcomes.

COLLABORATION PARTNERSHIP

#institution

#mobile app

View Analyst & Ambassador Comments
Go to original news
May 02,2024

Exclusive: Thyme Care launches virtual palliative care program, appoints medical director

Thyme Care is launching a new virtual palliative care program called Enhanced Supportive Care to support its members and their caregivers with managing physical and psychological symptoms related to cancer diagnosis and treatment. The program provides tailored support based on the member's cancer type and stage. For those with curative cancer, it includes coping mechanisms and communication strategies, while patients with advanced cancer receive end-of-life support and guidance on therapy options.

PRODUCT

#virtual care

View Analyst & Ambassador Comments
Go to original news
May 13,2024

Exclusive: Flatiron Health, Association of Cancer Care Centers partner for clinical trial data

Flatiron Health, a digital health company specializing in oncology, has partnered with the Association of Cancer Care Centers (ACCC) to enhance clinical trials in community settings. The collaboration aims to improve access to clinical trials, streamline data gathering, and boost efficiency using Flatiron's "Clinical Pipe" technology. This software connects electronic health records (EHRs) directly to electronic data capture (EDC) systems, automating the transfer of patient data and reducing manual data entry. The partnership seeks to accelerate research operations and increase patient access to oncology trials by making the process more efficient and interoperable across various healthcare settings.

COLLABORATION PARTNERSHIP

#institution

View Analyst & Ambassador Comments
Go to original news
Subscribe to ONCOLOGY